TUMOR NECROSIS FACTOR INHIBITOR

Open Access
Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases
Javier Bachiller-Corral, Alina Boteanu, Maria Jesus Garcia-Villanueva, Carlos de la Puente, Marcelino Revenga, M. Consuelo Diaz-Miguel, Ana Rodriguez-Garcia, Jose Luis Morell-Hita, Marta Valero, Carmen Larena, Maria Blazquez-Cañamero, Carlos A. Guillen-Astete, Sandra Garrote, Cristina Sobrino, Carmen Medina-Quiñones and Mónica Vazquez-Diaz

The Journal of Rheumatology July 1 2021, 48 (7) 1098-1102; DOI: https://doi.org/10.3899/jrheum.200755
You have access
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
Paul Emery, Bonnie Vlahos, Piotr Szczypa, Mazhar Thakur, Heather E. Jones, John Woolcott, Paul V. Santos Estrella, Catherine Rolland, Allan Gibofsky, Gustavo Citera, Sargunan Sockalingam and Lisa Marshall

The Journal of Rheumatology April 1 2020, 47 (4) 493-501; DOI: https://doi.org/10.3899/jrheum.181398
You have access
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry
Philip J. Mease, Tamara Lesperance, Mei Liu, David H. Collier, Marc Mason, Sabrina Deveikis and Neil A. Accortt

The Journal of Rheumatology February 1 2017, 44 (2) 184-192; DOI: https://doi.org/10.3899/jrheum.160343
You have access
Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry
Sofie H.M. Manders, Wietske Kievit, Tim L.T.A. Jansen, Jan N. Stolk, Henk Visser, Annemarie M. Schilder, Harald E. Vonkeman, Eddy Adang, Mart A.F.J. van de Laar and Piet L.C.M. van Riel

The Journal of Rheumatology October 1 2016, 43 (10) 1787-1794; DOI: https://doi.org/10.3899/jrheum.151014
Open Access
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Stephen Hall, Hector Chinoy, Alan J. Kivitz, Zailong Wang and Shephard Mpofu

The Journal of Rheumatology September 1 2016, 43 (9) 1713-1717; DOI: https://doi.org/10.3899/jrheum.160275
You have access
Concomitant Methotrexate Protects Against Total Knee Arthroplasty in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors
Shuji Asai, Nobunori Takahashi, Koji Funahashi, Yutaka Yoshioka, Toki Takemoto, Kenya Terabe, Nobuyuki Asai, Naoki Ishiguro and Toshihisa Kojima

The Journal of Rheumatology December 1 2015, 42 (12) 2255-2260; DOI: https://doi.org/10.3899/jrheum.150410
Open Access
Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
Alan J. Kivitz, Joy Schechtman, Michele Texter, Andreas Fichtner, Marc de Longueville and Elliot K. Chartash

The Journal of Rheumatology April 1 2014, 41 (4) 648-657; DOI: https://doi.org/10.3899/jrheum.130945
You have access
Changes in Body Mass Index in Children with Juvenile Idiopathic Arthritis Treated with Tumor Necrosis Factor Inhibitors
Ashley Shafferman, Kevin R. Fontaine, Randy Q. Cron and Timothy Beukelman

The Journal of Rheumatology January 1 2014, 41 (1) 113-118; DOI: https://doi.org/10.3899/jrheum.130159
You have access
Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial
Jeffrey R. Curtis, Theresa McVie, Ted R. Mikuls, Richard J. Reynolds, Iris Navarro-Millán, James O’Dell, Larry W. Moreland, S. Louis Bridges Jr., Veena K. Ranganath and Stacey S. Cofield

The Journal of Rheumatology May 1 2013, 40 (5) 572-578; DOI: https://doi.org/10.3899/jrheum.120715
You have access
Periarticular Bone Gain at Proximal Interphalangeal Joints and Changes in Bone Turnover Markers in Response to Tumor Necrosis Factor Inhibitors in Rheumatoid and Psoriatic Arthritis
Agnes Szentpetery, Malachi J. McKenna, Barbara F. Murray, Chin Teck Ng, Jennifer J. Brady, Michelle Morrin, Bea Radovits, Douglas J. Veale and Oliver FitzGerald

The Journal of Rheumatology May 1 2013, 40 (5) 653-662; DOI: https://doi.org/10.3899/jrheum.120397

Main menu

User menu

Search

TUMOR NECROSIS FACTOR INHIBITOR

Pages

Content

Resources

Subscribers

More